Clinical trial
Oasys vs. Extreme H20 Xtra 59
NCT00477763 · Innovative Medical, Industry · Completed
Key facts
| NCT number | NCT00477763 |
|---|---|
| Title | Oasys vs. Extreme H20 Xtra 59 |
| Official title | Oasys vs. Extreme H20 Xtra 59 |
| Lead sponsor | Innovative Medical, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dry Eye |
| Intervention type | Drug |
| Interventions | Restasis, Refresh Endura |
| Enrollment | 52 |
| Start date | May 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | May 24, 2007 |
| Last update posted | Feb 18, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: